India Acyclovir Market to grow at a steady rate During the Forecast Period
Growing prevalence of viral
diseases is expected to drive the growth of India acyclovir market.
According to
TechSci Research report, “India
Acyclovir Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule,
Ointment/Cream, Injection, Powder for Solution, Others), By Route of
Administration (Oral, Injectable, Topical, Others), By Type (Herpes
Simplex Virus Type I (HSV-1), Herpes Simplex (HSV-2), Varicella
Zoster Virus (VZV), Epstein-Barr Virus (EBV), Cytomegalovirus (CMV)), By
Mechanism of Action (Nucleotide Polymerase Inhibitors, Reverse Transcriptase
Inhibitors, Protease Inhibitors, Others), By Distribution Channel (Online v/s
Offline), By Application (Cold Soares, Chickenpox, Genital Herpes, Shingles,
Hepatitis, HIV, Influenza, Others), By End User (Children up to 12 years ), By Company, By Region, Forecast & Opportunities, FY2026”, the India acyclovir market is expected to grow at a steady
rate during the forecast period on account of the growing geriatric population
susceptible to diseases such as hepatitis, HIV, influenza, among others. This
has drastically increased the patient pool thereby increasing the demand for
the drug through FY2026. This in turn is expected to positively influence the
market growth over the next few years. However, side effects such as nausea,
vomiting, abdominal pain, among others due to consumption of acyclovir can
hamper the market growth over the next few years. Also, several other
side-effects on nervous system, renal system, hepatic system, among others can
be observed in certain patients due to the consumption of acyclovir. This
further slows down the market growth during the forecast period.
Browse XX market data
Tables and XX Figures spread through XX Pages and an in-depth TOC on" India Acyclovir Market"
https://www.techsciresearch.com/report/india-acyclovir-market/5148.html
The India
acyclovir market is segmented based on source, type, form, route of
administration, type of virus, mechanism of action, distribution channel,
application, end user, company and region. Based on source, the market can be
split into in-house and contract manufacturing organizations. The contract
manufacturing organizations (CMOs) segment is expected to witness significant
growth through FY2026 owing to the outsourcing being done by major
pharmaceutical companies to these organizations so that they can focus on their
research & development process for drug discovery. Based on form, the
market can be categorized into tablet, capsule, ointment/cream, injection,
powder for solution, others. The tablet segment is expected to dominate the
market owing to their cost-effectiveness, easy availability, among others.
Additionally, a tablet can accommodate a higher dose of API as compared to a
capsule. The ointment/ cream segment is expected to hold the largest market
share since they are used to treat the blisters and soars especially during
chickenpox. Based on route of administration, the market can be fragmented into
oral, injectable, topical and others. The oral route is expected to dominate
the market since in this route the drug is self-administered, it is pain free
and the absorption takes along the whole length of GI tract. Based on
distribution channel, the market can be bifurcated into online and offline. The
offline segment is expected to dominate the market on account of the well
established network of pharmacies in the country.
Cipla
Limited, Agio Pharmaceuticals Limited, Zee Laboratories Limited, Novus Life
Sciences Pvt. Ltd., Terrace Pharmaceuticals Pvt. Ltd., Grefith Life Sciences
Private Limited, Samarth Life Sciences Pvt. Ltd., Novartis India Limited
(Sandoz Private Limited), Cadila Healthcare Limited, Eli Lilly and Company
India Pvt Ltd. and others are some of the leading players operating in India acyclovir
market.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5148
Customers can
also request for 10% free customization on this report.
“India acyclovir market is
expected to witness growth during the forecast period on account of the supportive
government policies and schemes such as incentive linked production scheme for
production of 53 APIs in the country by domestic players, China plus one
Strategy, promotion and establishment of bulk drug parks, among others.
Additionally, the Pharma Vision 2020 which aims to make India self-sufficient
and establish itself in drug discovery, development and manufacturing is
further expected to fuel the market growth over the next few years.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Acyclovir Market By Source (In-house v/s Contract Manufacturing
Organizations), By Form (Tablet, Capsule, Ointment/Cream, Injection, Powder for
Solution, Others), By Route of Administration (Oral, Injectable, Topical,
Others), By Type of Virus (Herpes Simplex Virus Type I (HSV-1), Herpes Simplex
Virus Type II (HSV-2), Varicella Zoster Virus (VZV), Epstein-Barr Virus (EBV),
Cytomegalovirus (CMV)), By Mechanism of Action (Nucleotide Polymerase
Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Others), By
Distribution Channel (Online v/s Offline), By Application (Cold Soares,
Chickenpox, Genital Herpes, Shingles, Hepatitis, HIV, Influenza, Others), By
End User (Children up to 12 years ), By Company, By Region, Forecast
& Opportunities, FY2026”, has evaluated
the future growth potential of India acyclovir market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges and
opportunities in India acyclovir market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web:
https://www.techsciresearch.com/